A Study of Nivolumab Combined With Cabozantinib Compared to Sunitinib in Previously Untreated Advanced or Metastatic Renal Cell Carcinoma
Clinical trial NCT03141177 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03141177
- Sponsor
- Bristol-Myers Squibb
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-07-23
- Primary completion
- 2020-02-12
- Enrollment
- 701
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.